Valion Bio, Inc. closed fiscal year 2025 with $31.6M in total assets, $14.8M in total liabilities and $16.8M in shareholder equity. Total assets rose 1026.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Valion Bio, Inc. has filed alongside them.
Ticker history: TIVC became VBIO (Tivic Health Systems Inc) on . Earlier news and filings retain their original names and dates. View TIVC history.
Annual figures, oldest first. Point at a bar to read its period.
VBIO Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VBIO Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $32.5M+620.3% | $38.2M+911.8% | $31.6M+1026.0% | $6.2M+83.5% | $4.5M-5.7% | $3.8M+14.9% | $2.8M-45.6% | $3.4M-51.6% | $4.8M+4.1% | $3.3M-53.7% | $5.2M-12.2% | $7.0M-14.6% |
| Total Liabilities | $28.2M+3338.1% | $19.7M+2554.1% | $14.8M+5344.9% | $2.8M+402.7% | $821K+38.9% | $741K-34.6% | $272K-82.8% | $560K-54.9% | $591K-58.8% | $1.1M-40.2% | $1.6M-29.8% | $1.2M-49.0% |
| Total Equity | $4.2M+15.2% | $11.1M+264.4% | $16.8M+562.6% | $3.4M+20.5% | $3.7M-12.0% | $3.0M+41.0% | $2.5M-29.2% | $2.8M-50.8% | $4.2M+32.6% | $2.2M-58.6% | $3.6M-1.4% | $5.8M-0.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Valion Bio, Inc. financials
Frequently Asked Questions
Valion Bio, Inc. closed fiscal year 2025 with $31.6M in total assets, $14.8M in total liabilities and $16.8M in shareholder equity.
Valion Bio, Inc. (VBIO) total assets rose by 1026.0% year over year, from $2.8M to $31.6M in fiscal year 2025.
Across the 5 fiscal years this page covers, Valion Bio, Inc. (VBIO) total assets went from $15.0M in fiscal year 2021 to $31.6M in fiscal year 2025.
Valion Bio, Inc. (VBIO) reported $32.5M in total assets in Q2 2026. This represents an increase of 620.3% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Valion Bio, Inc. (VBIO) reported on that line in every period on record.